|
|
||||||||



* Department of Bioresource Chemistry, Obihiro University of Agriculture and Veterinary Medicine, Inada cho, Obihiro, Hokkaido, 080-8555, Japan
YAKULT Central Institute for Microbiological Research, 1796 Yaho, Kunitachi, Tokyo, 186-8650, Japan
Field Center of Animal Science and Agriculture, Obihiro University of Agriculture and Veterinary Medicine, Inada cho, Obihiro, Hokkaido, 080-8555, Japan
Corresponding author:
Tadashi Nakamura; E-mail address:
nakamura{at}obihiro.ac.jp.
| ABSTRACT |
|---|
|
|
|---|
2-3)Gal(ß1-4)Glc) reached a maximum value of 0.85 mg/ml immediately following parturition while the concentrations of 6'SL (Neu5Ac(
2-6)Gal(ß1-4)Glc) and 6'SLN (Neu5Ac(
2-6)Gal(ß1-4)GlcNAc) of 0.14 and 0.12 mg/ml, respectively, were much lower at this initial stage, although these concentration were maximum immediately following parturition. Bovine colostrum, especially that collected immediately after parturition, may be suitable as a source of 3'SL and other sialyloligosaccharides for use as additives by the food or pharmaceutical industries.
Key Words: sialyloligosaccharides pyridylamination bovine colostrum
Abbreviation key: 3'SL = Neu5Ac(
2-3)Gal(ß1-4)Glc, 6'SL = Neu5Ac(
2-6)Gal(ß1-4)Glc, 6'SLN = Neu5Ac(
2-6)Gal(ß1-4)GlcNAc, PA = pyridyl-2-amino
| INTRODUCTION |
|---|
|
|
|---|
Although the milk of most mammals contains lactose as the predominant carbohydrate, the milk or colostrum of many species also contains small amounts of free oligosaccharides, which usually have a lactose residue at their reducing ends. Bovine colostrum contains less free lactose but much higher concentrations of oligosaccharides and other glycoconjugates than the mature milk (Rook and Campling, 1965; Martin et al., 2001).
While the main significance of free lactose is as an energy source for the young, the sialyloligosaccharides and other sialylglycoconjugates are considered to be antiinfectional factors acting against rotavirus (Rolsma et al., 1998), rheovirus (Pacitti and Gentsch, 1987) and Helicobacter pylori (Simon et al., 1997). They also counteract Vibrio cholera toxin (Schengrund et al., 1989) and promote the growth of bifidobacteria in the neonatal intestinal tract (Rueda et al., 1998). It has been reported that bovine colostrum contains several kinds of sialyloligosaccharides including Neu5Ac(
2-3)Gal(ß1-4)Glc (3'SL), Neu5Ac(
2-6) Gal(ß1-4)Glc (6'SL) and Neu5Ac(
2-6)Gal(ß1-4)GlcNAc (6'SLN) (Parkkinen and Finne, 1987). However, there is a lack of detailed knowledge of the concentrations of sialyloligosaccharides in bovine colostrum. This paper describes the results of the determination of the concentrations of sialic acid and of these sialyloligosaccharides in bovine colostrum and milk during the early stages of lactation.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
Preparation of the crude sialyloligosaccharides fraction.
A 1 ml aliquot of each milk sample was warmed to 40°C and thoroughly mixed with 4 volumes of chloroform/methanol (2/1,v/v). After centrifugation at 2500 rpm for 30 min the methanol/water layer in the upper phase was concentrated by evaporation to remove the methanol, which was followed by lyophilization. The lyophilized material was dissolved in 1 ml of distilled water and applied to a Dowex 1X2 anion exchange column (acetate form), 1.5 x 6.0 cm (Dow Chemical Company, MI). Elution was done first with 50 ml of water (wash) and then with 50 ml of 1M NaCl solution and 5 ml fractions were collected. The hexose and sialic acid contents in an aliquot of each fraction were monitored by the phenol-H2SO4 and the periodic acid-resorcinol method, respectively. Fractions which contained both hexose and sialic acid were pooled and desalted by electrodialysis using a MICRO ACYLYZER model S-1 (Asahi Kasei Co., Kanagawa, Japan) with a 220-10 cartridge, followed by lyophilization.
Quantification of the sialyloligosaccharides.
The pyridylamino (PA) derivatives of the sialyloligosaccharide fractions were prepared according to the method of Hase et al. (1994) modified by Kimura et al. (1995), as described below. The coupling reagent contained 552 µg of 2-aminopyridine (Wako Pure Chemical Industries Ltd, Osaka, Japan) dissolved in 200 µl of acetic acid (Wako Pure Chemical Industries Ltd, Osaka, Japan). Of this reagent, 100 µl were added to the sialyloligosaccharide-containing fraction lyophilized in a glass tube (13 x 100 mm). The tube was sealed with a screw cap and heated at 90°C for 1 h, after which 100 µl of the reducing reagent, which contained 200 mg of Borane-dimethylamine complex (Aldrich Chemical Company Inc., USA) dissolved in 80 µl of acetic acid, were added. The tube was resealed and heated at 80°C for 50 min. The resulting PA derivatives were separated from the reaction mixture by electrodialysis using a MICRO ACYLYZER model S-1 (Asahi Kasei Co., Kanagawa, Japan), with a 220-10 cartridge, followed by lyophilization.
The PA sialyloligosaccharide fractions were each dissolved in 1 ml of distilled water and filtered through a DISMIC-13CP cellulose acetate membrane (0.45 µm, Advantec Toyo, Tokyo). Aliquots of the filtrates were subjected to normal phase HPLC. The analysis was performed on a Tosoh CCPM-intelligent pump system (Tosoh Co., Tokyo) using a TSKgel Amido-80 column (4.6 x 250 mm, pore size 80 nm, particle size 5 µm, Tosoh Co., Tokyo, Japan). The mobile phase was 50 and 80 % acetonitrile (CH3CN) in 15 mM potassium phosphate buffer (pH 5.2). Elution was done using a linear gradient of CH3CN from 80 to 50% for 80 min at 40°C at a flow rate of 1 ml/min. Detection was done with a MDPD-3600 multi-wavelength detector (Otsuka Electronics Co., Osaka, Japan) by monitoring the optical density of the eluate at 310 nm. Identification was done by comparison of the retention time of each peak of the PA derivative with those of sialyloligosaccharide standards. Each sialyloligosaccharide in the fraction was quantified by calculating the ratio of its peak area to the peak areas of the standards.
Statistical Analyses
Statistical analyses were conducted using SAS. Results were expressed as means ± SD.
| RESULTS |
|---|
|
|
|---|
|
|
| DISCUSSION |
|---|
|
|
|---|
Published data for sialic acid in bovine colostrum and milk differ considerably between various studies. Morrisey (1973) reported that the sialic acid content of early lactation bovine milk was 0.339 mg/ml while that of midlactation milk was 0.143 mg/ml. Martin et al. (2001), however, reported that on the second day of lactation the sialic acid content was about 0.560 mg/ml. On the other hand, Puente et al. (1992) reported that the sialic acid content rapidly decreased from 0.771 mg/ml during the morning of the first day of lactation to 0.165 mg/ml on the third day. These values are within the sialic acid contents from 0 to 168 h postpartum reported in this study. Our results showed a similar pattern of decrease in the sialic acid content from 0 to 168 h postpartum, but our value immediately after parturition was somewhat higher (0.853 mg/ml) than that of Puente et al. (1992). Martin et al. and Puente et al. collected the colostrum and milk samples from Spanish-Brown cows. The small differences of the values of the contents among this study and theirs may be caused by the differences of the breeds. It is also suggested that they are caused by the differences of the quantitative methods.
This study provides first information about changes in the concentrations of individual sialyloligosaccharides in bovine colostrum and milk during early lactation. Veh et al. (1981), who isolated 3'SL, 6'SL and 6'SLN from cows colostrum within 1 h postpartum, reported yields of 0.53 mg/ml, 0.065 mg/ml and 0.11 mg/ml, respectively. Our values for the concentrations of these oligosaccharides were somewhat higher than these, but it is possible that the differences were due to losses during the isolation of the sialyloligosaccharides by Veh et al. (1981). We determined each concentration of 3'SL, 6'SL and 6'SLN by HPLC analysis with their PA derivatives in the carbohydrate fractions in bovine colostrums and milk, but did not isolate each oligosaccharide. It is thought that the loss of the saccharides was smaller in our study than that of Veh et al. In this study, the concentrations of sialyloligosaccharides rapidly fell during the course of lactation until 2 to 3 d postpartum and were highest at 0 h postpartum, whereas the lactose concentration was lowest at that time. This indicates that the biosynthetic activity for the sialyloligosaccharides (i.e. sialyltransferase activity) is highest at the beginning of lactation. It is therefore, likely that sialyloligosaccharides are more important for newborns than for older calves.
There are a number of studies that have suggested that sialylglycoconjugates have several biological functions for human and other mammalian infants. A part of the sialyloligosaccharides in rat milk are absorbed intact, or hydrolysed by sialidase and then absorbed as free sialic acid, from the small intestine of rat infants (Dickson and Messer, 1978; Witt et al., 1979). The free sialic acid may then be used as a material for the synthesis of rat brain gangliosides (Morgan and Winick, 1979,1980,1981; Witt et al., 1979; Carlson and House, 1986). Brain gangliosides are rapidly formed during the neonatal period. Mammals can generally synthesize sialic acid via N-acetylmannosamine from fructose-6-phosphoric acid and glutamic acid. However, in newborn rats the activity of UDP-N-acetylglucosamine 2'-epimerase, which converts UDP-N-acetylglucosamine to N-acetylmannosamine, is low (Kikuchi et al., 1971). The neuraminidase activity of the intestinal mucosa of suckling rodents, rabbits and cats is higher than that of the adult animals (Dickson and Messer, 1978). It is likely, therefore, that some of the milk sialyloligoconjugates are a source of sialic acid for the newborns of these species. It is still unclear, however, whether this biological significance of milk sialyloligosaccharides is relevant to bovine newborns, which are much more highly developed at birth compared with neonatal rodents.
Nevertheless, it is known that, 3'SL, 6'SL and 6'SLN in milk are soluble receptor analogues for rotavirus, influenza virus A, B and Escherichia coli with S-fimbriae (Kawakami, 1974; Dai et al., 2000). E. coli is a pathogen which causes meningitis and septicemia in newborn infants. In fact, oral administration of N-glycolylneuraminic acid-containing ganglioside, which occurs in bovine colostrum, blood plasma and intestinal epithelium, has been shown to cure newborn calves infected with E. coli K99, a pathogen that causes diarrhea (Mouricot et al., 1990, Puente et al., 1992). These considerations suggest that the sialyl oligosaccharides in bovine colostrum protect the newborn against infection by these pathogenic microorganisms and bacterial toxins.
Rueda et al. (1998) observed that the addition of gangliosides to a milk formula, at the concentrations present in human milk, significantly modifies the fecal flora in preterm infants, with lower relative contents of E. coli and higher contents of bifidobacteria. Furthermore, Chierici et al. (1997) reported that a formula containing milk protein which had been desialylated by mild acid hydrolysis failed to induce a prevalence of colonization with bifidobacteria in 1-month-old infants, in contrast to breast-fed infants, 60% of which had detectable bifidus flora. This showed that sialylglycoconjugates in milk stimulate the colonization of the infant colon by bifidobacteria, most likely preventing the growth of pathogenic bacteria. The sialyloligosaccharides of bovine colostrum may have similar effects on newborn calves.
It is well known that the concentrations of milk constituents show considerable variation during the first week postpartum, especially during the first 48 h. Bovine colostrum, 48 h after parturition, contains significant amounts of immunoglobulins (Rook and Campling, 1965; Porter and Conrad, 1967). These immunoglobulins are absorbed from the small intestine of newborn calves and enter the blood circulation, thus contributing to prophylaxis. Thus, the consumption of colostrum for 1 or 2 d postpartum enables the calves to receive passive immunity from their mothers. The pattern of a postpartum decrease in the immunoglobulin concentration of bovine milk is similar to that of the sialyloligosaccharides (Rook and Campling, 1965; Porter and Conrad, 1967). The rapid decrease in both the sialyloligosaccharide and the immunoglobulin concentrations cannot be explained only in terms of a change in the milk yield. The higher concentration of sialyloligosaccharides in bovine colostrum during early lactation may be related to prophylaxis against attacks by pathogenic bacteria and viruses, and also to the development of the colonic bifidus flora, prior to the calves acquiring their own immunity. Future studies involving the administration of sialyloligosaccharides to calves may help to clarify their detailed functions.
This study shows that bovine colostrum collected immediately after parturition is rich in 3'SL, an oligosaccharide that has been shown to be a possible inhibitor of the actions of pathogenic microorganisms. Bovine colostrum, especially that collected immediately after parturition, may be suitable as a source of 3'SL and other sialyloligosaccharides to be used as additives in the food or pharmaceutical industries (Gopal and Gill, 2000).
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Received for publication May 20, 2002. Accepted for publication September 9, 2002.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G. Leitner, O. Krifucks, S. Jacoby, Y. Lavi, and N. Silanikove Concentrations of Ganglioside Type M1 and Immunoglobulin G in Colostrum Are Inversely Related to Bacterial Infection at Early Lactation in Cows J Dairy Sci, September 1, 2008; 91(9): 3337 - 3342. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |